NHS Rolls Out Discreet Cervical Cancer Home-Testing Kits as Screening Drive Expands
NHS launches discreet home-testing kits for cervical cancer in England to improve screening access and early detection.
The latest news on cancer screening, diagnosis and treatment, including new therapies, NHS services and research into prevention.
Alcohol-Linked Liver Cancer Deaths Reverse Course After Pandemic Disruptions, Study Finds
Alcohol-linked liver cancer deaths reversed course during the pandemic, new global data show, raising concern over screening delays.
NHS to contact half a million men as prostate cancer research drive expands
NHS England will contact 500,000 men for prostate cancer research as it expands prevention and community-based care.
First UK Patient Receives Bespoke Lung Cancer Vaccine in Landmark MRC Trial
The first UK patient receives a bespoke lung cancer vaccine in an MRC-funded trial testing personalised cancer treatment.
NHS Expands Research Drive as New Prostate Cancer Programme Opens to 500,000 Men
NHS England launches a major prostate cancer research drive, inviting 500,000 men to help improve early detection and treatment.
New Evidence Sheds Light on Cancer Cachexia Mechanism in Breakthrough Study
New research identifies a mechanism behind cancer cachexia, offering fresh hope for better treatment of the wasting condition.
NHS to Invite 500,000 Men Into Major Prostate Cancer Research Programme
NHS England will invite 500,000 men to join a major prostate cancer research programme aimed at earlier detection.
NHS Launches Major Prostate Cancer Research Drive as MenB Vaccination Boost Reaches Thousands
NHS launches a major prostate cancer research drive as MenB vaccination uptake among young people surges.
NHS Approves New Blood Cancer Drug for Children and Adults as July Reaches a Strong Finish
NHS England approves a new treatment policy for relapsed classical Hodgkin lymphoma as cancer care activity hits record levels.
NICE Recommends First NHS Treatment in Over 20 Years for Resistant Ovarian Cancer
NICE recommends mirvetuximab soravtansine, the first NHS treatment in over 20 years for resistant ovarian cancer.
